SCHEMBL5886646

SCHEMBL5886646

CCCCC#Cc1ccc(Cl)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 10/20 0.55
TNK2 Q07912 1/20 0.48
FFAR1 O14842 1/20 0.46
FFAR4 Q5NUL3 1/20 0.46
MMP2 P08253 2/20 0.45
MMP12 P39900 2/20 0.45
LMNA P02545 1/20 0.45
DRD2 P14416 1/20 0.41
MMP9 P14780 1/20 0.40
GABRP O00591 1/20 0.39
GABRD O14764 1/20 0.39
GABRA1 P14867 1/20 0.39
GABRB1 P18505 1/20 0.39
GABRG2 P18507 1/20 0.39
GABRB3 P28472 1/20 0.39
GABRA5 P31644 1/20 0.39
GABRA3 P34903 1/20 0.39
GABRA2 P47869 1/20 0.39
GABRB2 P47870 1/20 0.39
GABRA4 P48169 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9247329 0.94 KCNH2 (0.51) KCNH2TNK2FFAR1FFAR4MMP2
SCHEMBL5886641 0.92 KCNH2 (0.60) KCNH2TNK2FFAR1FFAR4MMP2
SCHEMBL5886588 0.89 FFAR1 (0.53) KCNH2TNK2FFAR1FFAR4MMP2
SCHEMBL9248307 0.89 KCNH2 (0.54) KCNH2TNK2FFAR1FFAR4MMP2
SCHEMBL8846653 0.87 FFAR1 (0.51) KCNH2TNK2FFAR1FFAR4MMP2
SCHEMBL9249094 0.82 KCNH2 (0.46) KCNH2TNK2MMP2MMP12LMNA
SCHEMBL28739809 0.82 KCNH2 (0.54) KCNH2TNK2FFAR1FFAR4MMP2
SCHEMBL5886652 0.81 FFAR1 (0.63) KCNH2TNK2FFAR1FFAR4MMP2
SCHEMBL4623168 0.80 FFAR1 (0.46) KCNH2TNK2FFAR1FFAR4MMP2
SCHEMBL6300169 0.80 LMNA (0.41) KCNH2TNK2FFAR1FFAR4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7105707-B2 Process for preparing alkynyl-substituted aromatic and heterocyclic compounds PHARMACORE, INC. (US) 2006-09-12 US disclosed
US-20050137402-A1 Process for preparing alkynyl-substituted aromatic and heterocyclic compounds DSM N.V. (NL) 2005-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050137402-A1 Process for preparing alkynyl-substituted aromatic and heterocyclic compounds NAT1, B3GNT2, NISCH KCNH2 559/4885TNK2 321/4885FFAR1 4642/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.